List of Excipients in API TRIAMTERENE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing TRIAMTERENE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Concordia Pharmaceuticals Inc | DYRENIUM | triamterene | 59212-002 | D&C RED NO. 33 | |
| Concordia Pharmaceuticals Inc | DYRENIUM | triamterene | 59212-002 | FD&C YELLOW NO. 6 | |
| Concordia Pharmaceuticals Inc | DYRENIUM | triamterene | 59212-002 | GELATIN | |
| Concordia Pharmaceuticals Inc | DYRENIUM | triamterene | 59212-002 | LACTOSE | |
| Concordia Pharmaceuticals Inc | DYRENIUM | triamterene | 59212-002 | MAGNESIUM STEARATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing TRIAMTERENE
Detailed excipient profiles for TRIAMTERENE
Excipient focus: ALCOHOL
TRIAMTERENE drug variants containing ALCOHOL
TRIAMTERENE drug variants not containing ALCOHOL
Excipient focus: ALUMINUM OXIDE
TRIAMTERENE drug variants containing ALUMINUM OXIDE
TRIAMTERENE drug variants not containing ALUMINUM OXIDE
Excipient focus: ANHYDROUS CITRIC ACID
TRIAMTERENE drug variants containing ANHYDROUS CITRIC ACID
TRIAMTERENE drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: ANHYDROUS LACTOSE
TRIAMTERENE drug variants containing ANHYDROUS LACTOSE
TRIAMTERENE drug variants not containing ANHYDROUS LACTOSE
Excipient focus: BUTYL ALCOHOL
TRIAMTERENE drug variants containing BUTYL ALCOHOL
TRIAMTERENE drug variants not containing BUTYL ALCOHOL
Excipient focus: CELLULOSE, MICROCRYSTALLINE
TRIAMTERENE drug variants containing CELLULOSE, MICROCRYSTALLINE
TRIAMTERENE drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CITRIC ACID
TRIAMTERENE drug variants containing CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | triamterene and hydrochlorothiazide | 21695-839 |
| >Company | >Ingredient | >NDC |
TRIAMTERENE drug variants not containing CITRIC ACID
Excipient focus: CITRIC ACID MONOHYDRATE
TRIAMTERENE drug variants containing CITRIC ACID MONOHYDRATE
TRIAMTERENE drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: CROSCARMELLOSE SODIUM
TRIAMTERENE drug variants containing CROSCARMELLOSE SODIUM
TRIAMTERENE drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: D&C RED NO. 33
TRIAMTERENE drug variants containing D&C RED NO. 33
| Company | Ingredient | NDC |
|---|---|---|
| Concordia Pharmaceuticals Inc | triamterene | 59212-002 |
| Prasco Laboratories | triamterene | 66993-831 |
| Carilion Materials Management | triamterene | 68151-1494 |
| TRUPHARMA LLC | triamterene capsules | 52817-364 |
| Bryant Ranch Prepack | triamterene capsules | 72162-2265 |
| >Company | >Ingredient | >NDC |
TRIAMTERENE drug variants not containing D&C RED NO. 33
Excipient focus: D&C YELLOW NO. 10
TRIAMTERENE drug variants containing D&C YELLOW NO. 10
TRIAMTERENE drug variants not containing D&C YELLOW NO. 10
Excipient focus: FD&C BLUE NO. 1
TRIAMTERENE drug variants containing FD&C BLUE NO. 1
TRIAMTERENE drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
TRIAMTERENE drug variants containing FD&C BLUE NO. 2
TRIAMTERENE drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE
TRIAMTERENE drug variants containing FD&C BLUE NO. 2--ALUMINUM LAKE
TRIAMTERENE drug variants not containing FD&C BLUE NO. 2--ALUMINUM LAKE
Excipient focus: FD&C RED NO. 40
TRIAMTERENE drug variants containing FD&C RED NO. 40
TRIAMTERENE drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
TRIAMTERENE drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Concordia Pharmaceuticals Inc | triamterene | 59212-002 |
| Prasco Laboratories | triamterene | 66993-831 |
| Carilion Materials Management | triamterene | 68151-1494 |
| TRUPHARMA LLC | triamterene capsules | 52817-364 |
| Bryant Ranch Prepack | triamterene capsules | 72162-2265 |
| >Company | >Ingredient | >NDC |
TRIAMTERENE drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE YELLOW
TRIAMTERENE drug variants containing FERRIC OXIDE YELLOW
TRIAMTERENE drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
TRIAMTERENE drug variants containing FERROSOFERRIC OXIDE
TRIAMTERENE drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
TRIAMTERENE drug variants containing GELATIN
TRIAMTERENE drug variants not containing GELATIN
Excipient focus: GLYCINE
TRIAMTERENE drug variants containing GLYCINE
TRIAMTERENE drug variants not containing GLYCINE
Excipient focus: HYPROMELLOSE
TRIAMTERENE drug variants containing HYPROMELLOSE
TRIAMTERENE drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
TRIAMTERENE drug variants containing HYPROMELLOSE 2910
TRIAMTERENE drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
TRIAMTERENE drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | triamterene and hydrochlorothiazide | 21695-496 |
| >Company | >Ingredient | >NDC |
TRIAMTERENE drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE
TRIAMTERENE drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Concordia Pharmaceuticals Inc | triamterene | 59212-002 |
| Prasco Laboratories | triamterene | 66993-831 |
| Carilion Materials Management | triamterene | 68151-1494 |
| >Company | >Ingredient | >NDC |
TRIAMTERENE drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
TRIAMTERENE drug variants containing LACTOSE MONOHYDRATE
TRIAMTERENE drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
TRIAMTERENE drug variants containing MAGNESIUM STEARATE
TRIAMTERENE drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHYL ALCOHOL
TRIAMTERENE drug variants containing METHYL ALCOHOL
TRIAMTERENE drug variants not containing METHYL ALCOHOL
Excipient focus: POLACRILIN POTASSIUM
TRIAMTERENE drug variants containing POLACRILIN POTASSIUM
TRIAMTERENE drug variants not containing POLACRILIN POTASSIUM
Excipient focus: POLYETHYLENE GLYCOL
TRIAMTERENE drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | triamterene and hydrochlorothiazide | 0378-2537 |
| Bryant Ranch Prepack | triamterene and hydrochlorothiazide | 71335-1039 |
| >Company | >Ingredient | >NDC |
TRIAMTERENE drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 8000
TRIAMTERENE drug variants containing POLYETHYLENE GLYCOL 8000
TRIAMTERENE drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYETHYLENE GLYCOLS
TRIAMTERENE drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | triamterene and hydrochlorothiazide | 0615-1333 |
| >Company | >Ingredient | >NDC |
TRIAMTERENE drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POLYSORBATE 80
TRIAMTERENE drug variants containing POLYSORBATE 80
TRIAMTERENE drug variants not containing POLYSORBATE 80
Excipient focus: POTASSIUM HYDROXIDE
TRIAMTERENE drug variants containing POTASSIUM HYDROXIDE
TRIAMTERENE drug variants not containing POTASSIUM HYDROXIDE
Excipient focus: POVIDONE
TRIAMTERENE drug variants containing POVIDONE
TRIAMTERENE drug variants not containing POVIDONE
Excipient focus: POWDERED CELLULOSE
TRIAMTERENE drug variants containing POWDERED CELLULOSE
TRIAMTERENE drug variants not containing POWDERED CELLULOSE
Excipient focus: PROPYLENE GLYCOL
TRIAMTERENE drug variants containing PROPYLENE GLYCOL
TRIAMTERENE drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
TRIAMTERENE drug variants containing SHELLAC
TRIAMTERENE drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
TRIAMTERENE drug variants containing SILICON DIOXIDE
TRIAMTERENE drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM BICARBONATE
TRIAMTERENE drug variants containing SODIUM BICARBONATE
TRIAMTERENE drug variants not containing SODIUM BICARBONATE
Excipient focus: SODIUM LAURYL SULFATE
TRIAMTERENE drug variants containing SODIUM LAURYL SULFATE
TRIAMTERENE drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
TRIAMTERENE drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
TRIAMTERENE drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STARCH, CORN
TRIAMTERENE drug variants containing STARCH, CORN
TRIAMTERENE drug variants not containing STARCH, CORN
Excipient focus: TITANIUM DIOXIDE
TRIAMTERENE drug variants containing TITANIUM DIOXIDE
TRIAMTERENE drug variants not containing TITANIUM DIOXIDE
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
